Global NewsNews
Dr Reddy’s launches generic drug in US market
The drug is used to treat gout due to high uric acid level
Dr Reddy’s Laboratories has launched Febuxostat tablets, used to treat gout due to high uric acid levels, in the US market. The company has launched the product, which is a generic version of Teijin’s Uloric tablets, after getting approval from the US Food and Drug Administration (US FDA), the company said in a regulatory filing.
THIS CAN BE YOUR ADVERTISEMENT
According to IQVIA Health, Uloric brand and generic versions had a sale of around $108 million (about Rs 790 crore) in the US for the most recent twelve months.
The Hyderabad-based firm said its product is available in 40 mg and 80 mg strengths in 30 tablets bottle count sizes.
PTI
Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.